e-Article
Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial
Document Type
Article
Author
Source
In Annals of Oncology June 2020 31(6):798-806
Subject
Language
ISSN
0923-7534